Tacrolimus,Methotrexate,Cyclophosphamide
pfizer
[]
#ash22 lba: pt-cy/tac/mtx as the new standard for gvhd in ric #bmt: ph iii 1703 trial
primary endpoint: 1 yr-grfs &gt; superior with pt-cy reduction in severe acute and chronic gvhd no diff in 1-yr trm, progression, os, dfs, day 100 chimerism, secondary gf 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??